3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Breast Neoplasms
12
Neoplasm Metastasis
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Salivary Gland Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasm, Residual
1
Mouth Neoplasms
1
Melanoma
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
HER2-positive Gastric Cancer
1
HER2-positive Breast Cancer
1
HER2-positive Advanced Gastric Cancer
1
HER2 Overexpression
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Drug-Related Side Effects and Adverse Reactions
1
Interventions
Surveys and Questionnaires
21
Blood Specimen Collection
9
Data Collection
7
Colposcopy
7
Surgical Procedures, Operative
5
Radiotherapy
5
Brachytherapy
5
Vaccines
4
Papanicolaou Test
4
Interviews as Topic
4
Cisplatin
4
Mass Screening
3
Magnetic Resonance Spectroscopy
3
Immunohistochemistry
3
Focus Groups
3
DNA Methylation
3
Specimen Handling
2
Sentinel Lymph Node Biopsy
2
Psychiatric Rehabilitation
2
Papillomavirus Vaccines
2
Observation
2
Neoadjuvant Therapy
2
Magnetic Resonance Imaging
2
Lymph Node Excision
2
Laparoscopy
2
Hysterectomy
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
Human Papillomavirus DNA Tests
2
High-Energy Shock Waves
2
Follow-Up Studies
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Uterine Cervical Neoplasms
×
trastuzumab deruxtecan
×
Clear all
NCT07124000
2026-06-01
DP-04
AstraZeneca
Recruiting
100 enrolled